Questionnaire design and the recall of pharmacological treatments: A systematic review

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 3, 2009, Pages 175-187

  Gama, Helena ^a,b   Correia, Sofia ^a,c   Lunet, Nuno ^a,c  

^a University of Porto   (Portugal)

^b DEPARTMENT OF RESEARCH AND DEVELOPMENT   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Data collection; Drug utilization; Epidemiologic methods; Pharmacoepidemiology; Questionnaire

Indexed keywords

ANALGESIC AGENT; ANTIMALARIAL AGENT; HERBACEOUS AGENT; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; DRUG;

CLINICAL ASSESSMENT; DRUG RESEARCH; DRUG USE; DRUG UTILIZATION; EXPERIMENTAL DESIGN; HUMAN; INTERMETHOD COMPARISON; INTERVIEW; OPEN ENDED QUESTIONNAIRE; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RECALL; REVIEW; SELF REPORT; SYSTEMATIC REVIEW; TREATMENT INDICATION; HEALTH SURVEY; OUTCOME ASSESSMENT; STATISTICS;

DRUG UTILIZATION; HEALTH SURVEYS; HUMANS; MENTAL RECALL; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACEUTICAL PREPARATIONS; QUESTIONNAIRES;

EID: 65249093264     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1703     Document Type: Review

References (41)

1. WHO Expert Commitee. The selection of essential drugs, Technical Report Series No. 615. Geneva: World Health Organization, 1977.
2. Strom BL. Pharmacoepidemiology (4th edn). John Wiley & Sons, Ltd, Chichester, UK. 2005.
3. Bergman U. The history of the drug utilization research group in Europe. Pharmacoepidemiol Drug Saf 2006; 15(2): 95-98.
4. Moore N, Pierfitte C, Pehourcq F, Lagnaoui R, Begaud B. Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects. Clin Pharmacol Ther 2001; 69(6): 445-450.
5. Capella D, Porta M, Laporte JR. Utilization of antihypertensive drugs in certain European countries. Eur J Clin Pharmacol 1983; 25(4): 431-435.
6. Laporte JR, Porta M, Capella D. Drug utilization studies: a tool for determining the effectiveness of drug use. Br J Clin Pharmacol 1983; 16(3): 301-304.
7. Boethius G. Approaches to assessing the rationality of drug usage in a developed country. Acta Med Scand Suppl 1988; 721: 21-26.
8. Boethius G, Wiman F. Recording of drug prescriptions in the county of Jamtland, Sweden. I. Methodological aspects. Eur J Clin Pharmacol 1977; 12(1): 31-35.
9. Duarte-Ramos F, Cabrita J. Using a pharmaco-epidemiological approach to estimate diabetes type 2 prevalence in Portugal. Pharmacoepidemiol Drug Saf 2006; 15(4): 269-274.
10. Hartz I, Sakshaug S, Furu K, et al. Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption: an individual-level prescription database study. BMC Clin Pharmacol 2007 Dec 5; 7-14.
11. Jacobus S, Schneeweiss S, Chan KA. Exposure misclassification as a result of free sample drug utilization in automated claims databases and its effect on a pharmacoepidemiology study of selective COX-2 inhibitors. Pharmacoepidemiol Drug Saf 2004; 13(10): 695-702.
12. Lau HS, de Boer A, Beuning KS, Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 1997; 50(5): 619-625.
13. Yood MU, Campbell UB, Rothman KJ, et al. Using prescription claims data for drugs available over-the-counter (OTC). Pharmacoepidemiol Drug Saf 2007; 16(9): 961-968.
14. Pont LG, Sturkenboom MC, van Gilst WH, Denig P, Haaijer-Ruskamp FM. Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000. Pharmacoepidemiol Drug Saf 2003; 12(4): 327-334.
15. Caamano F. Comment. Drug utilization studies. The need to know the indication. Gac Sanit 2008; 22(1): 19.
16. Delaney JA, Moodie EE, Suissa S. Validating the effects of drug treatment on blood pressure in the general practice research database. Pharmacoepidemiol Drug Saf 2008; 17(6): 535-545.
17. Wettermark B, Pehrsson A, Jinnerot D, Bergman U. Drug utilisation 90% profiles: a useful tool for quality assessment of prescribing in primary health care in Stockholm. Pharmacoepidemiol Drug Saf 2003; 12(6): 499-510.
18. Johnson RE, Vollmer WM. Comparing sources of drug data about the elderly. J Am Geriatr Soc 1991; 39(11): 1079-1084.
19. Psaty BM, Lee M, Savage PJ, Rutan GH, German PS, Lyles M. Assessing the use of medications in the elderly: methods and initial experience in the cardiovascular health study. The cardiovascular health study collaborative research group. J Clin Epidemiol 1992; 45(6): 683-692.
20. Klungel OH, de Boer A, Paes AH, Herings RM, Seidell JC, Bakker A. Influence of question structure on the recall of self-reported drug use. J Clin Epidemiol 2000; 53(3): 273-277.
21. Goodman MT, Nomura AM, Wilkens LR, Kolonel LN. Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol 1990; 131(5): 815-825.
22. Van den Brandt PA, Petri H, Dorant E, Goldbohm RA, Van de Crommert S. Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekbl Sci 1991; 13(2): 91-96.
23. Boynton PM, Greenhalgh T. Selecting, designing, and developing your questionnaire. BMJ 2004; 328(7451): 1312-1315.
24. Bowling A. Mode of questionnaire administration can have serious effects on data quality. J Public Health (Oxf) 2005; 27(3): 281-291.
25. Choi BC, Pak AW. A catalog of biases in questionnaires. Prev Chronic Dis 2005; 2(1): A13.
26. Ademi Z, Turunen JH, Kauhanen J, Enlund H. A comparison of three questionnaire-based measures of analgesic use over 11 years in adult males: a retrospective analysis of data from a prospective, populationbased cohort study. Clin Ther 2007; 29(3): 529-534.
27. de Jong-van den Berg LT, Waardenburg CM, Haaijer-Ruskamp FM, Dukes MN, Wesseling H. Drug use in pregnancy: a comparative appraisal of data collecting methods. Eur J Clin Pharmacol 1993; 45(1): 9-14.
28. Gmel G. Changing the order of questions on drug use in the Swiss health survey: does it effect prevalence assessment? Soz Praventivmed 1999; 44(3): 126-136.
29. Kimmel SE, Lewis JD, Jaskowiak J, Kishel L, Hennessy S. Enhancement of medication recall using medication pictures and lists in telephone interviews. Pharmacoepidemiol Drug Saf 2003; 12(1): 1-8.
30. Mitchell AA, Cottler LB, Shapiro S. Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol 1986; 123(4): 670-676.
31. Neutel CI, Walop W. Comparing two different approaches to measuring drug use within the same survey. Chronic Dis Can 2000; 21(4): 150-156.
32. Lunet N, Bastos J, Cumaio F, Silva P, Dias E, Barros H. Recall of drug utilization depends on subtle structural questionnaire characteristics. Pharm World Sci 2007.
33. West SL. A comparison of data sources for drug exposure ascertainment in pharmacoepidemiologic studies with emphasis on self-reported information. Pharmacoepidemiol Drug Saf 1997; 6(3): 215-218.
34. Haukka J, Suvisaari J, Tuulio-Henriksson A, Lonnqvist J. High concordance between self-reported medication and official prescription database information. Eur J Clin Pharmacol 2007; 63(11): 1069-1074.
35. Nielsen MW, Sondergaard B, Kjoller M, Hansen EH. Agreement between self-reported data on medicine use and prescription records vary according to method of analysis and therapeutic group. J Clin Epidemiol 2008.
36. Curtis JR, Westfall AO, Allison J, Freeman A, Kovac SH, Saag KG. Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users. Pharmacoepidemiol Drug Saf 2006; 15(10): 710-718.
37. Kelly JP, Rosenberg L, Kaufman DW, Shapiro S. Reliability of personal interview data in a hospital-based case-control study. Am J Epidemiol 1990; 131(1): 79-90.
38. Lewis JD, Strom BL, Kimmel SE, et al. Predictors of recall of over-thecounter and prescription non-steroidal anti-inflammatory drug exposure. Pharmacoepidemiol Drug Saf 2006; 15(1): 39-45.
39. Ray WA, Thapa PB, Gideon P. Misclassification of current benzodiazepine exposure by use of a single baseline measurement and its effects upon studies of injuries. Pharmacoepidemiol Drug Saf 2002; 11(8): 663-669.
40. de Almeida Neto AC, Chen TF, Chan JH. 'Order effect' in the provision of medication information. Med J Australia 2002; 176(8): 401-402.
41. Rosen T, Olsen J. Invited commentary: the art of making questionnaires better. Am J Epidemiol 2006; 164(12): 1145-1149.